| Drug Name |
Desflurane |
| Drug ID |
BADD_D00611 |
| Description |
Desflurane, or I-653, a a volatile anesthetic that is more rapidly cleared and less metabolized than previous inhaled anesthetics such as [methoxyflurane], [sevoflurane], [enflurane], or [isoflurane].[A226390,A39015,A226893]. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic.[A226883,A226888]
Desflurane was granted FDA approval on 18 September 1992.[L30285] |
| Indications and Usage |
Desflurane is indicated for the induction and maintenance of anesthesia in adults, as well as the maintenance of anesthesia in pediatric patients.[L30285] |
| Marketing Status |
approved |
| ATC Code |
N01AB07 |
| DrugBank ID |
DB01189
|
| KEGG ID |
D00546
|
| MeSH ID |
D000077335
|
| PubChem ID |
42113
|
| TTD Drug ID |
D0H4GN
|
| NDC Product Code |
0404-9961; 52584-641; 66794-021; 0781-6172; 10019-641; 57884-0028; 10019-644; 10019-646 |
| UNII |
CRS35BZ94Q
|
| Synonyms |
Desflurane | 1,2,2,2-Tetrafluoroethyl difluoromethyl ether | I 653 | I-653 | I653 | Suprane |
